PI3K-mTOR in Cancer and Cancer Therapy

In the post human-genome project era, cancer specific genomic maps are redesigning tumor taxonomy by evolving from histopathology to molecular pathology. The success of a cancer drug today is fundamentally based on the success in identifying target genes that control beneficial pathways. The overwhe...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Dey, Nandini (Editor ), De, Pradip (Editor ), Leyland-Jones, Brian (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Humana, 2016.
Edición:1st ed. 2016.
Colección:Cancer Drug Discovery and Development,
Temas:
Cancer.
Medicine-Research.
Biology-Research.
Medical microbiology.
Cancer Biology.
Biomedical Research.
Medical Microbiology.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • PI3K-Akt-mTOR Signaling in Cancer and Cancer Therapeutics
  • Part 1: PI3K-mTOR Pathway in Cancers
  • The mTOR Complexes in Cancer Cell Metabolism
  • PI3K-AKT-mTOR Pathway Co-operates with the DNA Damage Repair Pathway: Carcinogenesis in Triple Negative Breast Cancers and Beyond
  • The AKT-mTOR Signaling Pathway for Drug Response Prediction and Prognostic Signatures
  • Resistance to PI3K Pathway Inhibition
  • Part 2: PI3K-mTOR Pathway in Cancer Medicine
  • Combination Therapies Targeting the PI3K/AKT/mTOR Pathways
  • Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma
  • HER2 Signaling Network in Advanced Breast Cancer: Opportunities for Combination Therapies
  • The PI3K-mTOR Pathway in Prostate Cancer: Biological Significance and Therapeutic Opportunities.

Ejemplares similares